関連する実験動画
Updated: Sep 8, 2025

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
イタリアにおけるがん発生率と死亡率 (2013年−2017年)
Andrea Tittarelli1, Sabrina Fabiano1, Viviana Perotti1
1Cancer Registry Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Cancer epidemiology
|September 6, 2025
まとめ
イタリアの癌発生率と死亡率は (2013年−2017年) 地域によって大きく異なるが,北部ではより高い. 生涯がんのリスクは 男性2人に1人,女性3人に1人であり,予防の必要性を強調しています.
科学分野:
- 流行病学
- 腫瘍学
- 公衆衛生
背景:
- イタリアでは 人口増加と生活習慣の変化により 癌を含む慢性疾患が増加しています
- がんは公衆衛生上の大きな課題であり,流行病学的データを更新する必要がある.
研究 の 目的:
- イタリアにおけるがん発生率と死亡率 (2013年−2017年) の最新のデータを提供すること.
- 性別,癌の種類,地理的地域による癌率の分析
- 癌の生涯リスクを推定する
主な方法:
- AIRTUMネットワークの34の集団ベースの癌登録データを使用した.
- 年齢基準の発生率 (ASR) と死亡率 (ASMR) を計算した.
- 癌部位と性別による累積的な癌リスクの推定
主要な成果:
- 癌の症例は135万人以上で 男性の罹患率は高かった.
- 男女ともに,北イタリアで最も高いASRが観察されました.
- 死亡率は発症率の半分以下で 地域差はほとんどありませんでした
結論:
- 2人に1人の男性, 3人に1人の女性です.
- イタリア の 癌 の 数字 は ヨーロッパ の 傾向 に 適合 し て い ます.
- 癌の負担を軽減するために,国家政策とコミュニティベースの予防戦略が緊急に必要です.
関連する概念動画
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Prevalence and Incidence
783
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
783
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Statistical Methods for Analyzing Epidemiological Data
525
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
525
Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K

